News >

SABCS Showcased Novel Agents in the HER2+ Breast Cancer Armamentarium

Jessica Hergert
Published: Thursday, Feb 06, 2020

Katherine D. Crew, MD

Katherine D. Crew, MD

On the heels of the 2019 San Antonio Breast Cancer Symposium (SABCS), Katherine D. Crew, MD, highlighted practice-changing novel agents entering the treatment paradigm in advanced HER2-positive breast cancer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication